Research Abstract
I am an academic medical oncologist specializing in gastrointestinal (GI) malignancies to focus on the treatment of patients with GI malignancies, with a particular focus on anal cancer, colorectal cancer, and GI neuroendocrine cancers as well as general GI oncology. I previously worked in the laboratory of Dr. Carol L. Rosenberg at Boston University School of Medicine and Dr. Donald E. Ingber at the Wyss Institute. I joined the faculty of Beth Israel Deaconess Medical Center (BIDMC) in 2014 and served as a GI oncologist as well as the Director of Inpatient Hematology and Oncology during my tenure at BIDMC. At BIDMC, I was an active participant in investigator-initiated, cooperative group, and industry funded clinical trials in GI malignancies, as well as trials involving the management of thrombosis in cancer. In my role at BIDMC, I served as a weekly discussant in the Gastrointestinal Malignancies Tumor Board and Pancreaticobiliary Malignancies Tumor Board. I saw patients in the Rectal Cancer Multidisciplinary Clinic and the Pancreatic Cancer Multidisciplinary Clinic as well as my general GI oncology clinic. I also mentored numerous fellows and residents in oncology. My current clinical activities at DFCI include five half-day sessions in the GI oncology and four weeks per year of inpatient attending service in oncology at BWH. I am refocusing my efforts on clinical investigation, using my experience as a practicing oncologist to help develop innovative clinical trials in GI malignancies. My background in clinical practice, clinical trials, medical education, and laboratory work will serve as a solid foundation for this transition.